Bulk Manufacturer of Controlled Substances Registration, 52908-52909 [2016-18921]
Download as PDF
<![CDATA[
52908
Federal Register / Vol. 81, No. 154 / Wednesday, August 10, 2016 / Notices
replace the volume of articles
potentially subject to the recommended
orders within a commercially
reasonable time; and
(v) explain how the recommended
orders would impact consumers in the
United States.
Written submissions must be filed no
later than by close of business on
September 6, 2016.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to
Commission Rule 210.4(f), 19 CFR
210.4(f). Submissions should refer to the
investigation number (‘‘Inv. No. 947’’) in
a prominent place on the cover page
and/or the first page. (See Handbook for
Electronic Filing Procedures, https://
www.usitc.gov/secretary/fed_reg_
notices/rules/handbook_on_electronic_
filing.pdf). Persons with questions
regarding filing should contact the
Secretary, (202) 205–2000.
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel, solely for cybersecurity
purposes. All contract personnel will
sign appropriate nondisclosure
agreements. All non-confidential
written submissions will be available for
public inspection at the Office of the
Secretary and on EDIS.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and part 210 of the Commission’s Rules
of Practice and Procedure (19 CFR part
210).
Company
mstockstill on DSK3G9T082PROD with NOTICES
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
17:34 Aug 09, 2016
Jkt 238001
[FR Doc. 2016–18904 Filed 8–9–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as an importer of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUMMARY:
FR Docket
Mylan Pharmaceuticals, Inc. ...................................................
Hospira ....................................................................................
Cambrex Charles City ............................................................
Pharmacore ............................................................................
Mallinckrodt LLC .....................................................................
Meda Pharmaceuticals, Inc. ...................................................
Stepan Company ....................................................................
VerDate Sep<11>2014
By order of the Commission.
Issued: August 4, 2016.
Lisa R. Barton,
Secretary to the Commission.
80
81
81
81
81
81
81
FR
FR
FR
FR
FR
FR
FR
Published
75691 ..........................................................................
1208 ............................................................................
14892 ..........................................................................
15565 ..........................................................................
15566 ..........................................................................
15560 ..........................................................................
20417 ..........................................................................
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed persons.
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as bulk
manufacturers of various classes of
controlled substances.
SUMMARY:
The
companies listed below applied to be
registered as manufacturers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
for these notices.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2016–18922 Filed 8–9–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
PO 00000
Notice of registration.
Frm 00099
Fmt 4703
Sfmt 4703
December 3, 2015.
January 11, 2016.
March 18, 2016.
March 23, 2016.
March 23, 2016.
March 23, 2016.
April 7, 2016
E:\FR\FM\10AUN1.SGM
10AUN1
52909
Federal Register / Vol. 81, No. 154 / Wednesday, August 10, 2016 / Notices
Company
FR Docket
Noramco, Inc. ..........................................................................................
Cayman Chemical Company ..................................................................
Janssen Pharmaceutical, Inc. .................................................................
Insys Therapeutics, Inc. ..........................................................................
Siemens Healthcare Diagnostics, Inc. ....................................................
Siegfried USA, LLC .................................................................................
Patheon Pharmaceuticals, Inc. ...............................................................
Navinta, LLC ............................................................................................
Patheon API Manufacturing, Inc. ............................................................
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of these registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each of the company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed persons.
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–18921 Filed 8–9–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
mstockstill on DSK3G9T082PROD with NOTICES
Notice of Lodging Proposed Consent
Decree
In accordance with Departmental
Policy, 28 CFR 50.7, notice is hereby
given that a proposed Consent Decree in
Dan Eoff v. United States Environmental
Protection Agency, Civil Action No.
4:13–cv–00368–DPM, was lodged with
the United States District Court for the
Eastern District of Arkansas, Western
Division, on August 4, 2016.
This proposed Consent Decree
concerns a complaint filed by Plaintiff
and Counterclaim Defendant Dan Eoff
against the United States Environmental
Protection Agency, and an answer and
counterclaim filed by the United States,
on behalf of the United States
Environmental Protection Agency,
against Dan Eoff pursuant to Section
301(a) of the Clean Water Act, to obtain
injunctive relief from and impose civil
penalties against the Plaintiff and
Counterclaim Defendant for violating
VerDate Sep<11>2014
17:34 Aug 09, 2016
Jkt 238001
81
81
81
81
81
81
81
81
81
FR
FR
FR
FR
FR
FR
FR
FR
FR
7587 ....................................
9217 ....................................
9219 ....................................
9220 ....................................
15565 ..................................
15567 ..................................
15571 ..................................
20418 ..................................
22122 ..................................
the Clean Water Act by discharging
pollutants without a permit into waters
of the United States. The proposed
Consent Decree resolves these
allegations by requiring Mr. Eoff to
restore the impacted areas, perform
mitigation and pay a civil penalty.
The Department of Justice will accept
written comments relating to this
proposed Consent Decree for thirty (30)
days from the date of publication of this
Notice. Please address comments to Lisa
Bell, Trial Attorney and John E.
Sullivan, Trial Attorney for the United
States Department of Justice,
Environment and Natural Resources
Division, Environmental Defense
Section, Post Office Box 7611,
Washington, DC 20044 and refer to Dan
Eoff v. United States Environmental
Protection Agency, DJ # 90–5–1–4–
19920.
The proposed Consent Decree may be
examined at the Clerk’s Office, United
States District Court for the Eastern
District of Arkansas, Western Division,
600 West Capitol Avenue, Suite A149,
Little Rock, AR 72201. In addition, the
proposed Consent Decree may be
examined electronically at https://
www.justice.gov/enrd/consent-decrees.
Cherie L. Rogers,
Assistant Section Chief, Environmental
Defense Section, Environment and Natural
Resources Division.
[FR Doc. 2016–18933 Filed 8–9–16; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Water
Act
On August 4, 2016, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the Western District of
Pennsylvania in the lawsuit entitled
United States and the Pennsylvania
Department of Environmental
Protection v. CONSOL Energy Inc., et
al., Civil Action No. 2:16–CV–01178.
The proposed Consent Decree will
resolve Clean Water Act and associated
PO 00000
Frm 00100
Fmt 4703
Published
Sfmt 4703
February 12, 2016.
February 24, 2016.
February 24, 2016.
February 24, 2016.
March 23, 2016.
March 23, 2016.
March 23, 2016.
April 7, 2016.
April 14, 2016.
state claims alleged in this action by the
United States and the Pennsylvania
Department of Environmental Protection
Against CONSOL Energy Inc., CNX Coal
Resources LP, and Consol Pennsylvania
Coal Company LLC for the discharge of
pollutants from the Bailey Mine
Complex in Greene and Washington
Counties, Pennsylvania, into state
waters and waters of the United States
in violation of limits in National
Pollutant Discharge Elimination System
(‘‘NPDES’’) permits. Under the proposed
Consent Decree, Defendants will
perform injunctive relief including
implementing water management
measures to prevent contaminated
discharge, conducting long-term
monitoring to ensure sufficient storage
capacity to prevent future discharges,
developing contingency plans should
future discharges become likely, and
implementing an environmental
management system to ensure
compliance with the Clean Water Act
and other applicable environmental
laws. In addition, Defendants will pay a
total civil penalty of $3 million in three
installments, with the last payment on
January 15, 2018.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and should refer to
United States and the Pennsylvania
Department of Environmental
Protection v. CONSOL Energy Inc. et al.,
D.J. Ref. No. 90–5–1–1–10614. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcommentees.enrd@usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Pages 52908-52909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18921]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by-the Drug Enforcement Administration (DEA) as bulk
manufacturers of various classes of controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as manufacturers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted for these
notices.
[[Page 52909]]
------------------------------------------------------------------------
Company FR Docket Published
------------------------------------------------------------------------
Noramco, Inc.................... 81 FR 7587........ February 12, 2016.
Cayman Chemical Company......... 81 FR 9217........ February 24, 2016.
Janssen Pharmaceutical, Inc..... 81 FR 9219........ February 24, 2016.
Insys Therapeutics, Inc......... 81 FR 9220........ February 24, 2016.
Siemens Healthcare Diagnostics, 81 FR 15565....... March 23, 2016.
Inc..
Siegfried USA, LLC.............. 81 FR 15567....... March 23, 2016.
Patheon Pharmaceuticals, Inc.... 81 FR 15571....... March 23, 2016.
Navinta, LLC.................... 81 FR 20418....... April 7, 2016.
Patheon API Manufacturing, Inc.. 81 FR 22122....... April 14, 2016.
------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823(a) and
determined that the registration of these registrants to manufacture
the applicable basic classes of controlled substances is consistent
with the public interest and with United States obligations under
international treaties, conventions, or protocols in effect on May 1,
1971. The DEA investigated each of the company's maintenance of
effective controls against diversion by inspecting and testing each
company's physical security systems, verifying each company's
compliance with state and local laws, and reviewing each company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the DEA has granted a registration as a bulk manufacturer
to the above listed persons.
Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18921 Filed 8-9-16; 8:45 am]
BILLING CODE 4410-09-P
